摘要
剂量-反应Meta分析(dose-response meta-analysis,DRMA)作为Meta分析的分支之一,为临床研究提供了重要的证据。自其被引入国内后,已引起广泛关注。为改善国内DRMA的报告质量,徐畅等制定了DRMA的报告规范,并于2016年发表在《中国循证医学杂志》。本文就该报告规范进行解读,以期促进作者理解和使用该报告规范。
Dose-response meta-analysis (DRMA) is one of the branches of meta-analysis, which has provided important evidence for clinical research. Since introducing into China, it has gained great attention. In order to improve the reporting quality of DRMA, Dr. Chang Xu et al. developed the reporting guideline for DAMA G-Dose Checklist. It was published in Chinese ]ouranl of Evidence-based Medicine in 2016. This paper interprets the checklists so as to promote the understanding and use of it.
出处
《中国循证医学杂志》
CSCD
2017年第6期736-741,共6页
Chinese Journal of Evidence-based Medicine
基金
湖北省教育厅重点项目(编号:D20142102)
关键词
剂量-反应Meta分析
报告规范
解读
Meta-analysis of dose-response
Reporting guideline
Interpretation